SLN
Silence Therapeutics·NASDAQ
--
--(--)
--
--(--)
2.78 / 10
Underperform
SLN's fundamental assessment is underwhelming, earning a 2.8/10 score and classified as Underperform. Key weaknesses include low current and fixed assets turnover ratios (both scoring 0/3), while revenue-MV, profit-MV, and gross margin perform moderately well. The PB-ROE factor of 0.6178 places the stock in a higher-risk quartile historically associated with 6.78% one-month returns. Overall, the fundamental picture calls for prudence, as inventory and asset utilization inefficiencies temper otherwise solid gross margins and cash-flow metrics.
Analysis Checks(6/10)
Revenue-MV
Value-5.58
Score2/3
Weight20.08%
1M Return11.31%
Value-5.58
Score2/3
Weight20.08%
1M Return11.31%
Gross profit margin (%)
Value61.33
Score2/3
Weight2.20%
1M Return1.40%
Value61.33
Score2/3
Weight2.20%
1M Return1.40%
Net income-Revenue
Value-0.15
Score2/3
Weight14.03%
1M Return8.04%
Value-0.15
Score2/3
Weight14.03%
1M Return8.04%
Current assets turnover ratio
Value0.00
Score0/3
Weight-3.21%
1M Return-2.30%
Value0.00
Score0/3
Weight-3.21%
1M Return-2.30%
Asset-MV
Value-0.51
Score1/3
Weight19.38%
1M Return9.84%
Value-0.51
Score1/3
Weight19.38%
1M Return9.84%
Inventory turnover ratio
Value47.88
Score3/3
Weight9.06%
1M Return5.89%
Value47.88
Score3/3
Weight9.06%
1M Return5.89%
Profit-MV
Value0.47
Score2/3
Weight13.84%
1M Return7.95%
Value0.47
Score2/3
Weight13.84%
1M Return7.95%
PB-ROE
Value0.62
Score1/3
Weight12.73%
1M Return6.78%
Value0.62
Score1/3
Weight12.73%
1M Return6.78%
Fixed assets turnover ratio
Value0.27
Score1/3
Weight-1.83%
1M Return-1.34%
Value0.27
Score1/3
Weight-1.83%
1M Return-1.34%
Cash-MV
Value-0.07
Score2/3
Weight13.71%
1M Return7.78%
Value-0.07
Score2/3
Weight13.71%
1M Return7.78%
Revenue-MV
Value-5.58
Score2/3
Weight20.08%
1M Return11.31%
Value-5.58
Score2/3
Weight20.08%
1M Return11.31%
Inventory turnover ratio
Value47.88
Score3/3
Weight9.06%
1M Return5.89%
Value47.88
Score3/3
Weight9.06%
1M Return5.89%
Gross profit margin (%)
Value61.33
Score2/3
Weight2.20%
1M Return1.40%
Value61.33
Score2/3
Weight2.20%
1M Return1.40%
Profit-MV
Value0.47
Score2/3
Weight13.84%
1M Return7.95%
Value0.47
Score2/3
Weight13.84%
1M Return7.95%
Net income-Revenue
Value-0.15
Score2/3
Weight14.03%
1M Return8.04%
Value-0.15
Score2/3
Weight14.03%
1M Return8.04%
PB-ROE
Value0.62
Score1/3
Weight12.73%
1M Return6.78%
Value0.62
Score1/3
Weight12.73%
1M Return6.78%
Current assets turnover ratio
Value0.00
Score0/3
Weight-3.21%
1M Return-2.30%
Value0.00
Score0/3
Weight-3.21%
1M Return-2.30%
Fixed assets turnover ratio
Value0.27
Score1/3
Weight-1.83%
1M Return-1.34%
Value0.27
Score1/3
Weight-1.83%
1M Return-1.34%
Asset-MV
Value-0.51
Score1/3
Weight19.38%
1M Return9.84%
Value-0.51
Score1/3
Weight19.38%
1M Return9.84%
Cash-MV
Value-0.07
Score2/3
Weight13.71%
1M Return7.78%
Value-0.07
Score2/3
Weight13.71%
1M Return7.78%
Is SLN fundamentally strong?
- SLN scores 2.78/10 on fundamentals and holds a Premium valuation at present. Backed by its -73.86% ROE, -249.86% net margin, -3.48 P/E ratio, 3.03 P/B ratio, and 23.41% earnings growth, these metrics solidify its Underperform investment rating.
